Skip to main content
Clinical Trials/ISRCTN61735247
ISRCTN61735247
Completed
未知

Control of Hyperglycaemia In Paediatric intensive care

Royal Brompton & Harefiled NHS Trust (UK)0 sites1,500 target enrollmentJanuary 24, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Hyperglycaemia
Sponsor
Royal Brompton & Harefiled NHS Trust (UK)
Enrollment
1500
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2007
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Brompton & Harefiled NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Children from birth to 16 years who are undergoing intensive care treatment with an arterial line in\-situ and receiving both mechanical ventilation and vasoactive support drugs following injury, major surgery or in association with critical illness in whom it is anticipated such treatment will be required to continue for at least 12 hours.

Exclusion Criteria

  • 1\. Children born pre\-term and who are \< 36 weeks corrected gestation
  • 2\. Children with diabetes mellitus
  • 3\. Children with an established or suspected diagnosis of an inborn error of metabolism
  • 4\. Children for whom treatment withdrawal or limitation of intensive care treatment is being considered
  • 5\. Children who have been in a PICU for more than 5 days in succession
  • 6\. Children admitted to a PICU who have already participated in the CHIP study during a previous PICU admission

Outcomes

Primary Outcomes

Not specified

Similar Trials